📰 Newspapers

Strain-specific Ebola jab trials to start in DR Congo next week: WHO

Strain-specific Ebola jab trials to start in DR Congo next week: WHO

GENEVA: Two potential vaccines against the deadly Ebola strain gripping the Democratic Republic of Congo are set to enter trials in the outbreak’s epicenter next week, the WHO announced Tuesday. There are currently no vaccines or treatments for the less common Bundibugyo species of Ebola behind the explosive outbreak declared in May, triggering an international public health emergency. A total of 5,568 deaths out of 11,376 cases have been confirmed in the vast central African country’s worst-ever Ebola outbreak, according to the World Health Organization. “We expect two candidate vaccines developed specifically for Bundibugyo virus to begin testing as early as next week,” WHO chief Tedros Adhanom Ghebreyesus told a press conference at the UN health agency’s headquarters in Geneva. The so-called Tumaini trial in the DRC is a single framework that can test the safety, efficacy and ability to trigger an immune response of multiple vaccines. The trial uses ring vaccination: immunizing contacts deemed to be at high risk of infection. Ervebo, a vaccine already approved for use against the more common Zaire strain of Ebola, kicked off the Tumaini trial on October 23, at the full-scale Phase 3 level, to determine if it also offers any protection against Bundibugyo.

The trial will now also incorporate the two Bundibugyo-specific candidate vaccines, which have both gone through earlier-stage, smaller-scale Phase…

In brief

GENEVA: Two potential vaccines against the deadly Ebola strain gripping the Democratic Republic of Congo are set to enter trials in the outbreak’s epicenter next week, the WHO announced Tuesday. There are currently no vaccines or treatments for the less common Bundibugyo species of Ebola behind the explosive outbreak declared in May, triggering an international public health emergency. The trial will now also incorporate the two Bundibugyo-specific candidate vaccines, which have both gone through earlier-stage, smaller-scale Phase…

This is the opening of the story, shared with credit to Arab News. The rest of the report — with every detail — continues on the publisher’s website.

Continue reading at Arab News ↗

Cookie settings

Choose which cookies we may use. You can change this at any time from Cookie settings in the footer. Details of each cookie are in the Cookie Policy.

Strictly necessary

Needed for sign-in, security, payments and remembering these choices. Always on.

Preferences

Remember settings such as dark mode.

Analytics & performance

Help us count visits, understand which pages, devices and countries our readers use, and measure how well the site performs – anonymous and aggregated.

Advertising & marketing

Lets advertising partners show and personalise adverts, measure impressions, clicks and visits, prevent ad fraud and pay us – this is how the free site is funded.

🔔 News notifications

Get headlines from NewsHub on this device — even when the site is closed.

You can switch this off at any time. Works on Android, Windows, Mac and Linux browsers; on iPhone/iPad add the site to your Home Screen first.